Safe procedures despite ultra low radiation doses during catheter ablations of atrial and ventricular arrhythmias-A multicenter experience.


Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
May 2021
Historique:
revised: 05 01 2021
received: 30 06 2020
accepted: 07 02 2021
pubmed: 6 3 2021
medline: 20 1 2022
entrez: 5 3 2021
Statut: ppublish

Résumé

Despite the development of non-fluoroscopic catheter visualization options, fluoroscopy is still used in most ablation procedures. The aim of this multicenter study was to evaluate the safety and efficacy of a new ultra-low dose radiation protocol for EP procedures in a large number of patients. A total of 3462 consecutive patients (male 1926 (55.6%), age 64.4 ± 14.0 years, BMI 26.65 ± 4.70) undergoing radiofrequency ablation (left atrial (n = 2316 [66.9%], right atrial (n = 675 [19.5%], or ventricular (n = 471 [13.6%]) in three German centers were included in the analysis. Procedures were performed using a new ultra-low dose protocol operating at 8nGy for fluoroscopy and 36nGy for cine-loops. Additionally a very low framerate (2-3FPS) was used. Using the new protocol very low Air kerma-area product (KAP) values were achieved for left atrial ablations (104.25 ± 84.22 μGym The ultra-low dose, low framerate protocol leads to very low radiation doses for all EP procedures while neither procedural time, fluoroscopy time nor success or complication rates were compromised. When compared to current real-world Air KAP data the new ultra-low dose fluoroscopy protocol reduces radiation exposure by more than 90%.

Identifiants

pubmed: 33665850
doi: 10.1111/pace.14205
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

807-813

Informations de copyright

© 2021 The Authors. Pacing and Clinical Electrophysiology published by Wiley Periodicals LLC.

Références

Bourier F, Reents T, Ammar-Busch S, et al. Evaluation of a new very low dose imaging protocol: feasibility and impact on X-ray dose levels in electrophysiology procedures. Europace. 2016;18:1406-1410.
Attanasio P, Schreiber T, Pieske B, et al. Pushing the limits: establishing an ultra-low framerate and antiscatter grid-less radiation protocol for left atrial ablations. Europace. 2018;20:604-607.
Dehairs M, Bosmans H, Desmet W, Marshall NW. Evaluation of automatic dose rate control for flat panel imaging using a spatial frequency domain figure of merit. Phys Med Biol. 2017;62:6610-6630.
Vañó E, Miller DL, Martin CJ, et al. Diagnostic reference levels in medical imaging. ICRP Publication 135. Ann ICRP. 2017;46:1-144.
Roguin A, Goldstein J, Bar O, Goldstein JA. Brain and neck tumors among physicians performing interventional procedures. Am J Cardiol. 2013;111:1368-1372.
Buchanan GL, Chieffo A, Mehilli J, et al. The occupational effects of interventional cardiology: results from the WIN for Safety survey. EuroIntervention. 2012;8:658-663.
Sommer P, Bertagnolli L, Kircher S, et al. Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures. Europace. 2018;20:1952-1958.
Lehrmann H, Jadidi AS, Minners J, et al. Important reduction of the radiation dose for pulmonary vein isolation using a multimodal approach. Europace. 2018;20:279-287.
Thibault B, Macle L, Mondésert B, et al. Reducing radiation exposure during procedures performed in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 2018;29:308-315.
Estner HL, Grazia Bongiorni M, Chen J, Dagres N, Hernandez-Madrid A, Blomström-Lundqvist C. Scientific initiative committee, European Heart Rhythm Use of fluoroscopy in clinical electrophysiology in Europe: results of the European Heart Rhythm Association Survey. Europace. 2015;17:1149-1152.
ICRP, Diagnostic reference levels in medical imaging. ICRP Publication 135. Ann. ICRP 2017;46:1-144.
Grecu M, Blomström-Lundqvist C, Kautzner J, ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term Registry investigators. et al. In-hospital and 12-month follow-up outcome from the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term Registry: sex differences. Europace. 2019;22(1):66-73.
Cappato R, Calkins H, Chen S-A, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32-38.
Kleemann T, Brachmann J, Lewalter T, et al. Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage. Clin Res Cardiol. 2016;105:858-864.
Holmqvist F, Kesek M, Englund A, et al. A decade of catheter ablation of cardiac arrhythmias in Sweden: ablation practices and outcomes. Eur Heart J. 2019;40:820-830.

Auteurs

Philipp Attanasio (P)

Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.

Martin Huemer (M)

Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.

Nora Kaehler (N)

Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.

Theresa Keller (T)

Institute for Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Tobias Schreiber (T)

Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.

Reinhard Niehues (R)

Augusta Krankenhaus Düsseldorf, Department of Cardiology, Academic Teaching Hospital of the University Faculty of Health, Düsseldorf, Germany.

Dimitra Katsani-Potempa (D)

Augusta Krankenhaus Düsseldorf, Department of Cardiology, Academic Teaching Hospital of the University Faculty of Health, Düsseldorf, Germany.

Rolf Michael Klein (RM)

Augusta Krankenhaus Düsseldorf, Department of Cardiology, Academic Teaching Hospital of the University Faculty of Health, Düsseldorf, Germany.
Department of Cardiology, University Hospital Witten/Herdecke, Witten, Germany.

Ulf Landmesser (U)

Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.

Isabel Deisenhofer (I)

Department of Electrophysiology, German Heart Center Munich, Munich, Germany.

Osman Tutdibi (O)

Augusta Krankenhaus Düsseldorf, Department of Cardiology, Academic Teaching Hospital of the University Faculty of Health, Düsseldorf, Germany.

Felix Bourier (F)

Department of Electrophysiology, German Heart Center Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH